Company Filing History:
Years Active: 2013-2018
Title: Innovator Daniel Bimmler: Advancing Sepsis Detection
Introduction: Daniel Bimmler, an accomplished inventor based in Kuesnacht, Switzerland, has made significant contributions to the field of medical diagnostics. With a total of two patents to his name, his work focuses on innovative methods for predicting sepsis in humans, particularly after traumatic injuries.
Latest Patents: Bimmler's latest patents revolve around a method for assaying sepsis in humans. This invention presents a reliable technique for predicting the onset of sepsis in patients following trauma. By determining the levels of pancreatic stone protein/regenerating protein (PSP/reg) in serum, high levels of this biomarker signal the potential development of sepsis at the disease's early stages. Furthermore, the patent details a precise method for measuring PSP/reg levels in serum.
Career Highlights: Daniel Bimmler is currently associated with the University of Zurich, where he collaborates with fellow researchers to enhance medical diagnostics. His contributions continue to play a crucial role in advancing healthcare solutions.
Collaborations: Throughout his career, Bimmler has worked alongside esteemed colleagues such as Rolf Graf and Marius Keel. Together, they combine their expertise to innovate and improve methods for disease detection and management.
Conclusion: As an inventor, Daniel Bimmler's work is pivotal in the realm of medical technology, particularly in combating sepsis, a critical condition requiring swift diagnosis and treatment. His innovative patents reflect his commitment to enhancing patient care and the overall field of medical diagnostics.